NEUROCRINE BIOSCIENCES INC (NBIX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
NBIX currently has 101M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 1.4% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 05, 2026 |
10-Q filing | 100.5M shares outstanding |
100M | 0 |
| Oct 28, 2025 |
10-Q filing | 99.4M shares outstanding |
99M | 0 |
| May 05, 2025 |
10-Q filing | 99.7M shares outstanding |
100M | 0 |
| Feb 10, 2025 |
10-K filing | 100.4M shares outstanding |
100M | 0 |
| Oct 30, 2024 |
10-Q filing | 101.1M shares outstanding |
100M | 0 |
| Aug 01, 2024 |
10-Q filing | 100.8M shares outstanding |
100M | 0 |
| May 01, 2024 |
10-Q filing | 99.8M shares outstanding |
100M | 0 |
| Feb 09, 2024 |
10-K filing | 101.0M shares outstanding |
100M | 0 |
| Oct 31, 2023 |
10-Q filing | 97.9M shares outstanding |
98M | 0 |
| Aug 01, 2023 |
10-Q filing | 97.6M shares outstanding |
98M | 0 |
| May 03, 2023 |
10-Q filing | 97.1M shares outstanding |
97M | 0 |
| Feb 24, 2023 |
8-K filing: Neurocrine Biosciences, Inc. purchased 4,395,588 shares of Voyager Therapeutics Limited's common stock at $8.88 per share on February 23, 2023. ($39.0M proceeds) |
96M | 0 |
| Feb 09, 2023 |
10-K filing | 95.8M shares outstanding |
96M | 0 |
| Jan 09, 2023 |
8-K filing: Neurocrine Biosciences, Inc. entered into a Collaboration and License Agreement with Voyager Therapeutics, Inc. and a stock purchase agreement for the sale and issuance of 4,395,588 shares of Voyager common stock to Neurocrine at a price of $8.88 per share, for an aggregate purchase price of approximately $39.0 million. ($39.0M proceeds) |
96M | 0 |
| Nov 01, 2022 |
10-Q filing | 95.8M shares outstanding |
96M | 0 |
| Aug 04, 2022 |
10-Q filing | 95.6M shares outstanding |
96M | 0 |
| May 04, 2022 |
10-Q filing | 95.3M shares outstanding |
95M | 0 |
| Feb 11, 2022 |
10-K filing | 94.6M shares outstanding |
95M | 0 |
| Nov 01, 2021 |
10-Q filing | 94.7M shares outstanding |
95M | 0 |
| Aug 03, 2021 |
10-Q filing | 94.6M shares outstanding |
95M | 0 |
| May 05, 2021 |
10-Q filing | 94.2M shares outstanding |
94M | 0 |
| Feb 05, 2021 |
10-K filing | 93.1M shares outstanding |
93M | 0 |
| Nov 09, 2020 |
10-Q filing | 93.3M shares outstanding |
93M | 0 |
| Aug 03, 2020 |
10-Q filing | 93.0M shares outstanding |
93M | 0 |
| May 06, 2020 |
10-Q filing | 92.6M shares outstanding |
93M | 0 |
| Feb 07, 2020 |
10-K filing | 91.6M shares outstanding |
92M | 0 |